Spire Healthcare Group plc (LON:SPI)
London · Delayed Price · Currency is GBP · Price in GBX 146.20
-4.60 (-3.05%)
At close: Mar 26, 2026
Spire Healthcare Group Market Cap
Spire Healthcare Group has a market cap or net worth of 604.03 million as of March 26, 2026. Its market cap has decreased by -13.73% in one year.
Market Cap
604.03M
Enterprise Value
1.89B
Revenue
1.58B
Ranking
n/a
PE Ratio
37.70
Stock Price
146.20
Market Cap Chart
Since July 18, 2014, Spire Healthcare Group's market cap has increased from 211.00 to 604.03M, an increase of 286,269,988.15%. That is a compound annual growth rate of 256.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 604.03M | -10.11% |
| Dec 31, 2025 | 671.96M | -26.12% |
| Dec 31, 2024 | 909.51M | -0.63% |
| Dec 29, 2023 | 915.29M | -0.60% |
| Dec 30, 2022 | 920.82M | -8.12% |
| Dec 31, 2021 | 1.00B | 60.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.19B |
| GSK plc | 79.07B |
| Haleon | 32.06B |
| Smith & Nephew | 10.24B |
| Oxford Nanopore Technologies | 1.13B |
| CVS Group | 806.80M |
| Oxford Biomedica | 716.78M |
| Allergy Therapeutics | 664.92M |